ECEESPE2025 Poster Presentations Pituitary, Neuroendocrinology and Puberty (162 abstracts)
Impact of disease activity on cognitive and psychological outcomes in acromegaly: a prospective study
Serhat Uysal 1 , Zehra Kara 1 , Cem Sulu 1 , Serdar Sahin 1 , Ahmet Demir 1 , Esra Gungormus 1 , Selin Yagci Kurtish 1 , Elif Ersoy Yilmaz 1 , Senol Turan 1 , Hande Ozkaya 1 & Pinar Kadioglu 1
1Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye
JOINT1972
Purpose: To investigate the cognitive and psychological aspects of acromegaly and to assess how disease activity may affect these outcomes.
Methods: This prospective study included patients with acromegaly between 18 and 65 years of age who consecutively admitted to Pituitary Center between June 2021 and July 2023. Cognitive functions were assessed using a series of standardized tests targeting memory, attention, executive function, verbal fluency, and visuospatial skills. Additionally, Beck Depression Inventory (BDI), Beck Anxiety Inventory, and Acromegaly Quality of Life Questionnaire (AcroQoL) assessments were conducted. These evaluations were performed preoperatively and at the 9th month postoperatively following transsphenoidal surgery (TSS) to assess the anticipated changes in neuropsychological functions based on disease activity.
Results: A total of 19 patients with acromegaly were included in the study. Remission was achieved through TSS alone in 9 patients, while 10 patients required postoperative somatostatin receptor ligands. Cognitive functions (Montreal Cognitive Assessment Test) were better in the remission phase compared to the initial active disease phase (23.36±3.46 vs 24.93±3.73; p=0.035). Cognitive flexibility and selective attention (Stroop Test) were impaired during the active period of the disease (17.79±12.31 vs 12.29±8.23; p=0.016). Memory functions (Wechsler Memory Scale-Logical Memory Test: immediate recall, delayed recall, recognition) showed improvement from the active phase to remission (p=0.016, p=0.003, p=0.008; respectively). BDI scores were significantly higher in the active phase compared to remission (7.36±3.48 vs 5.43±3.03; p=0.009). Additionally, AcroQoL scores were lower during the active disease phase than in the remission phase (76.21±16.02 vs 92.86±11.97; p=0.007).
Conclusions: Acromegaly may impair cognitive and psychological functions, which appear to improve with effective treatment.
Volume 110
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more